Cancer Patients With Breakthrough COVID-19 Remain at Risk for Severe Outcomes
No significant difference observed in 30-day mortality for fully vaccinated versus unvaccinated cancer patients with COVID-19
Cancer
Cancer Patients May Have Double the Risk of Breakthrough Infection After COVID-19 Vaccination
A meta-analysis suggests that patients with cancer may be twice as likely as non-cancer patients to have a breakthrough infection after being fully vaccinated.
COVID-19 Deaths on the Decline in Patients With Cancer
Registry data show significant decreases in 14-day and 3-month case-fatality rates.
Drug Metabolism May Be Suppressed in Patients With Inflammatory Conditions
Suppressed drug metabolism was identified in patients with various inflammatory conditions.
Procedures to Diagnose Cancer, New Cancer Diagnoses Decreased in 2020
Colonoscopies decreased by 45% in 2020 compared with averages in 2018 through 2019; 29% decrease seen in prostate biopsies
Most Immunosuppressive Meds Not Tied to Worse COVID-19 Outcomes
Except for rituximab, no increased risk seen for in-hospital death or mechanical ventilation for those on long-term immunosuppressive therapy
Blacks, Hispanics Still Underrepresented in Cancer Clinical Trials
Odds of participation up for Blacks, Hispanics in breast, lung, prostate cancer trials in 2015 to 2019 compared with 2000 to 2004
Effects of Fasting-Mimicking Diet Studied in Cancer Patients
Fasting-mimicking diets induce metabolic and immunologic changes that might enhance the effects of standard antineoplastic therapy
Patient Economic Burden for Cancer Care $21.1 Billon in 2019
Annualized net out-of-pocket costs were highest in the initial and end-of-life phases, lowest in continuing care phase
Unemployment Adversely Linked to Recommended Cancer Screening
Lower prevalence of screening for unemployed adults was no longer seen after accounting for health insurance coverage
- Loading...
Loading...
Next post in Practice Management
Loading... 
Loading...